Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:22 pm Sale | 2022-12-30 | 13G | Travere Therapeutics, Inc. TVTX | Macquarie Group Limited | 3,555,992 5.540% | -211,900 (-5.62%) | Filing History |
| 2023-02-14 1:39 pm Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 6,412,000 9.990% | 2,334,000 (+57.23%) | Filing History |
| 2023-02-14 08:59 am Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 4,582,000 7.140% | 1,146,800 (+33.38%) | Filing History |
| 2023-02-10 5:27 pm Sale | 2022-12-30 | 13G | Travere Therapeutics, Inc. TVTX | GOLDMAN SACHS GROUP INC GS | 3,142,175 4.900% | -1,457,104 (-31.68%) | Filing History |
| 2023-02-10 11:50 am Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 5,091,285 7.900% | 1,075,127 (+26.77%) | Filing History |
| 2023-02-09 11:35 am Sale | 2022-12-30 | 13G | Travere Therapeutics, Inc. TVTX | The Vanguard Group | 3,515,446 5.480% | -365,427 (-9.42%) | Filing History |
| 2023-02-09 11:04 am Sale | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,600,000 4.050% | -1,327,000 (-33.79%) | Filing History |
| 2023-02-06 2:55 pm Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | STATE STREET CORP STT | 4,224,024 6.580% | 4,224,024 (New Position) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | BlackRock Inc. BLK | 5,194,785 8.100% | 679,640 (+15.05%) | Filing History |
| 2022-10-28 4:30 pm Purchase | 2022-10-18 | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,927,000 6.140% | 2,624,508 (+201.50%) | Filing History |
| 2022-05-16 4:55 pm Purchase | 2022-05-06 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 3,435,200 5.410% | 985,200 (+40.21%) | Filing History |
| 2022-02-14 5:22 pm Purchase | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 4,078,000 6.700% | 4,078,000 (New Position) | Filing History |
| 2022-02-14 4:50 pm Sale | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Perceptive Advisors LLC | 1,845,555 3.000% | -1,648,052 (-47.17%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | RA Capital Management, L.P. | 5,614,428 9.200% | 1,056,561 (+23.18%) | Filing History |
| 2022-02-14 10:24 am Purchase | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Macquarie Group Limited | 3,767,892 6.150% | 1,003,970 (+36.32%) | Filing History |
| 2022-02-14 09:01 am Sale | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 2,450,000 4.000% | -640,200 (-20.72%) | Filing History |
| 2022-02-10 5:22 pm Sale | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 4,016,158 6.600% | -67,395 (-1.65%) | Filing History |
| 2022-02-10 11:11 am Sale | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,302,492 2.130% | -1,547,508 (-54.30%) | Filing History |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | The Vanguard Group | 3,880,873 6.340% | 476,430 (+13.99%) | Filing History |
| 2022-02-02 7:18 pm Sale | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | BlackRock Inc. BLK | 4,515,145 7.400% | -310,029 (-6.43%) | Filing History |